| 000 | 01787 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516104649.0 | ||
| 264 | 0 | _c20130411 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1522-1598 | ||
| 024 | 7 |
_a10.1152/jn.00185.2012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrkic, Ivana | |
| 245 | 0 | 0 |
_aPontine μ-opioid receptors mediate bradypnea caused by intravenous remifentanil infusions at clinically relevant concentrations in dogs. _h[electronic resource] |
| 260 |
_bJournal of neurophysiology _cNov 2012 |
||
| 300 |
_a2430-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xtoxicity |
| 650 | 0 | 4 |
_aAnesthetics, Intravenous _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBrain Mapping |
| 650 | 0 | 4 |
_aDiaphragm _xinnervation |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEnkephalin, Ala(2)-MePhe(4)-Gly(5)- _xpharmacology |
| 650 | 0 | 4 | _aHyperoxia |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aNaloxone _xpharmacology |
| 650 | 0 | 4 |
_aNarcotic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aPhrenic Nerve _xphysiology |
| 650 | 0 | 4 |
_aPiperidines _xtoxicity |
| 650 | 0 | 4 |
_aPons _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Opioid, mu _xagonists |
| 650 | 0 | 4 | _aRemifentanil |
| 650 | 0 | 4 |
_aRespiratory Rate _xdrug effects |
| 700 | 1 | _aMustapic, Sanda | |
| 700 | 1 | _aRadocaj, Tomislav | |
| 700 | 1 | _aStucke, Astrid G | |
| 700 | 1 | _aStuth, Eckehard A E | |
| 700 | 1 | _aHopp, Francis A | |
| 700 | 1 | _aDean, Caron | |
| 700 | 1 | _aZuperku, Edward J | |
| 773 | 0 |
_tJournal of neurophysiology _gvol. 108 _gno. 9 _gp. 2430-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1152/jn.00185.2012 _zAvailable from publisher's website |
| 999 |
_c22010287 _d22010287 |
||